This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thompson, P. A. Articles by Ambrosone, C. B. Search for Related Content PubMed PubMed Citation Articles by Thompson, P. A. Articles by Ambrosone, C. B.

Genetic Polymorphisms in Catechol-O-Methyltransferase, Menopausal Status, and Breast Cancer Risk¹

Division of Molecular Epidemiology, National Center for Toxicological Research, Jefferson, Arkansas 72205 [P. A. T., A. S., F. F. K., C. B. A.]; Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 [P. G. S.]; Department of Social & Preventive Medicine, State University of New York at Buffalo, Buffalo, New York 14214 [J. L. F., J. E. V., S. G., R. L., T. N.]; and Arizona Cancer Center, Tucson, Arizona 85724 [J. R. M.]

Polymorphic catechol-O-methyltransferase (COMT) catalyzes the O-methylation of estrogen catechols. In a case-control study, we evaluated the association of the low-activity allele (COMT^Met) with breast cancer risk. Compared to women with COMT^Val/Val, COMT^Met/Met was associated with an increased risk among premenopausal women [odds ratio (OR), 2.1; confidence interval (CI), 1.4–4.3] but was inversely associated with postmenopausal risk (OR, 0.4; CI, 0.2–0.7). The association of risk with at least one low-activity COMT^Met allele was strongest among the heaviest premenopausal women (OR, 5.7; CI, 1.1–30.1) and among the leanest postmenopausal women (OR, 0.3; CI, 0.1–0.7), suggesting that COMT, mediated by body mass index, may be playing differential roles in human breast carcinogenesis, dependent upon menopausal status.

¹ This work was a collaborative effort by the Division of Molecular Epidemiology, National Center for Toxicological Research, the Department of Social and Preventive Medicine, State University of New York at Buffalo, and the Laboratory of Human Carcinogenesis, National Cancer Institute. This work was supported, in part, by Grants CA11535, CA/ES62995, and CA01633 from the National Cancer Institute and the National Institute for Environmental Health Sciences and USAMRMC#CAMC17-94-J-4108. This work is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute.

² To whom requests for reprints should be addressed, at Division of Molecular Epidemiology, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079. E-mail:cambrosone@nctr.fda.gov.

Received 11/24/97. Accepted 3/19/98.

This article has been cited by other articles:

				K. W. Reding, N. S. Weiss, C. Chen, C. I. Li, C. S. Carlson, H.-W. Wilkerson, F. M. Farin, K. E. Thummel, J. R. Daling, and K. E. Malone Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1461 - 1467. [Abstract] [Full Text] [PDF]

				Y. Ji, J. Olson, J. Zhang, M. Hildebrandt, L. Wang, J. Ingle, Z. Fredericksen, T. Sellers, W. Miller, J. M. Dixon, et al. Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms Cancer Res., July 15, 2008; 68(14): 5997 - 6005. [Abstract] [Full Text] [PDF]

				A. Hazra, S. Chanock, E. Giovannucci, D. G. Cox, T. Niu, C. Fuchs, W. C. Willett, and D. J. Hunter Large-Scale Evaluation of Genetic Variants in Candidate Genes for Colorectal Cancer Risk in the Nurses' Health Study and the Health Professionals' Follow-up Study Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 311 - 319. [Abstract] [Full Text] [PDF]

				P. T. Campbell, L. Edwards, J. R. McLaughlin, J. Green, H. B. Younghusband, and M. O. Woods Cytochrome P450 17A1 and Catechol O-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland Clin. Cancer Res., July 1, 2007; 13(13): 3783 - 3788. [Abstract] [Full Text] [PDF]

				A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49. [Abstract] [Full Text] [PDF]

				K. M. Gooden, J. C. Schroeder, K. E. North, M. D. Gammon, K. E. Hartmann, J. Taylor, and D. D. Baird Val153Met Polymorphism of Catechol-O-Methyltransferase and Prevalence of Uterine Leiomyomata Reproductive Sciences, February 1, 2007; 14(2): 117 - 120. [Abstract] [PDF]

				D. T. Redden, P. G. Shields, L. Epstein, E. P. Wileyto, S. O. Zakharkin, D. B. Allison, and C. Lerman Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1384 - 1389. [Abstract] [Full Text] [PDF]

				W. Wen, Q. Cai, X.-O. Shu, J.-R. Cheng, F. Parl, L. Pierce, Y.-T. Gao, and W. Zheng Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 329 - 335. [Abstract] [Full Text] [PDF]

				H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort Hum. Reprod., February 1, 2005; 20(2): 536 - 542. [Abstract] [Full Text] [PDF]

				M. McGrath, S. E. Hankinson, L. Arbeitman, G. A. Colditz, D. J. Hunter, and I. De Vivo Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility Carcinogenesis, April 1, 2004; 25(4): 559 - 565. [Abstract] [Full Text] [PDF]

				A. H. Wu, C.-C. Tseng, D. Van Den Berg, and M. C. Yu Tea Intake, COMT Genotype, and Breast Cancer in Asian-American Women Cancer Res., November 1, 2003; 63(21): 7526 - 7529. [Abstract] [Full Text] [PDF]

				C.-C. Hong, H. J. Thompson, C. Jiang, G. L. Hammond, D. Tritchler, M. Yaffe, and N. F. Boyd Val158Met Polymorphism in Catechol-O-methyltransferase Gene Associated with Risk Factors for Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 838 - 847. [Abstract] [Full Text] [PDF]

				M. Sasaki, M. Kaneuchi, N. Sakuragi, and R. Dahiya Multiple Promoters of Catechol-O-methyltransferase Gene Are Selectively Inactivated by CpG Hypermethylation in Endometrial Cancer Cancer Res., June 15, 2003; 63(12): 3101 - 3106. [Abstract] [Full Text] [PDF]

				Y.-P. Fu, J.-C. Yu, T.-C. Cheng, M. A. Lou, G.-C. Hsu, C.-Y. Wu, S.-T. Chen, H.-S. Wu, P.-E. Wu, and C.-Y. Shen Breast Cancer Risk Associated with Genotypic Polymorphism of the Nonhomologous End-Joining Genes: A Multigenic Study on Cancer Susceptibility Cancer Res., May 15, 2003; 63(10): 2440 - 2446. [Abstract] [Full Text] [PDF]

				S. Wedren, T. R. Rudqvist, F. Granath, E. Weiderpass, M. Ingelman-Sundberg, I. Persson, and C. Magnusson Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk Carcinogenesis, April 1, 2003; 24(4): 681 - 687. [Abstract] [Full Text] [PDF]

				E. I. O. Garner, E. E. Stokes, R. S. Berkowitz, S. C. Mok, and D. W. Cramer Polymorphisms of the Estrogen-metabolizing Genes CYP17 and Catechol-O-methyltransferase and Risk of Epithelial Ovarian Cancer Cancer Res., June 1, 2002; 62(11): 3058 - 3062. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				J. A. Lavigne, J. E. Goodman, T. Fonong, S. Odwin, P. He, D. W. Roberts, and J. D. Yager The Effects of Catechol-O-Methyltransferase Inhibition on Estrogen Metabolite and Oxidative DNA Damage Levels in Estradiol-treated MCF-7 Cells Cancer Res., October 1, 2001; 61(20): 7488 - 7494. [Abstract] [Full Text] [PDF]

				J. E. Goodman, J. A. Lavigne, K. Wu, K. J. Helzlsouer, P. T. Strickland, J. Selhub, and J. D. Yager COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk Carcinogenesis, October 1, 2001; 22(10): 1661 - 1665. [Abstract] [Full Text] [PDF]

				S. Dawling, N. Roodi, R. L. Mernaugh, X. Wang, and F. F. Parl Catechol-O-Methyltransferase (COMT)-mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms Cancer Res., September 1, 2001; 61(18): 6716 - 6722. [Abstract] [Full Text] [PDF]

				K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, D. Kang, H. Vainio, M. Uusitupa, and A. Hirvonen Polymorphic Catechol-O-methyltransferase Gene and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 635 - 640. [Abstract] [Full Text] [PDF]

				L. A. Poirier, C. K. Wise, R. R. Delongchamp, and R. Sinha Blood Determinations of S-Adenosylmethionine, S-Adenosylhomocysteine, and Homocysteine: Correlations with Diet Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 649 - 655. [Abstract] [Full Text] [PDF]

				R. Todorovic, P. Devanesan, S. Higginbotham, J. Zhao, M. L. Gross, E. G. Rogan, and E. L. Cavalieri Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol Carcinogenesis, June 1, 2001; 22(6): 905 - 911. [Abstract] [Full Text] [PDF]

				M. T. Goodman, K. McDuffie, L. N. Kolonel, K. Terada, T. A. Donlon, L. R. Wilkens, C. Guo, and L. Le Marchand Case-Control Study of Ovarian Cancer and Polymorphisms in Genes Involved in Catecholestrogen Formation and Metabolism Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 209 - 216. [Abstract] [Full Text]

				J. E. Goodman, J. A. Lavigne, J. G. Hengstler, B. Tanner, K. J. Helzlsouer, and J. D. Yager Catechol-O-Methyltransferase Polymorphism Is Not Associated with Ovarian Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1373 - 1376. [Abstract] [Full Text]

				J. A. Williams and D. H. Phillips Mammary Expression of Xenobiotic Metabolizing Enzymes and Their Potential Role in Breast Cancer Cancer Res., September 1, 2000; 60(17): 4667 - 4677. [Abstract] [Full Text]

				B. Paquette, P.-K. Fortier, J. Héroux, P. A Thibodeau, R. Wagner, J. Liu, and A. Cantin Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved Thorax, July 1, 2000; 55(7): 574 - 578. [Abstract] [Full Text]

				J. D. Yager Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 67 - 73. [Abstract] [Full Text] [PDF]

				C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al. Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112. [Abstract] [Full Text] [PDF]

				R. Raftogianis, C. Creveling, R. Weinshilboum, and J. Weisz Chapter 6: Estrogen Metabolism by Conjugation J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 113 - 124. [Abstract] [Full Text] [PDF]

				P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF]

				J. Weisz, G. Fritz-Wolz, S. Gestl, G. A. Clawson, C. R. Creveling, J. G. Liehr, and D. Dabbs Nuclear Localization of Catechol-O-Methyltransferase in Neoplastic and Nonneoplastic Mammary Epithelial Cells Am. J. Pathol., June 1, 2000; 156(6): 1841 - 1848. [Abstract] [Full Text] [PDF]

				D. A. Elson, R. R. Riley, A. Lacey, G. Thordarson, F. J. Talamantes, and J. M. Arbeit Sensitivity of the Cervical Transformation Zone to Estrogen-induced Squamous Carcinogenesis Cancer Res., March 1, 2000; 60(5): 1267 - 1275. [Abstract] [Full Text]

				W. Zheng, D.-W. Xie, F. Jin, J.-R. Cheng, Q. Dai, W.-Q. Wen, X.-O. Shu, and Y.-T. Gao Genetic Polymorphism of Cytochrome P450-1B1 and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 147 - 150. [Abstract] [Full Text]

				C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans Cancer Res., February 1, 2000; 60(4): 950 - 956. [Abstract] [Full Text]

				P. T. Mannisto and S. Kaakkola Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors Pharmacol. Rev., December 1, 1999; 51(4): 593 - 628. [Abstract] [Full Text] [PDF]

				S. S. Coughlin and M. Piper Genetic Polymorphisms and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 1023 - 1032. [Full Text]

				A. M. Dunning, C. S. Healey, P. D. P. Pharoah, M. D. Teare, B. A. J. Ponder, and D. F. Easton A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 843 - 854. [Abstract] [Full Text]

				C.-S. Huang, H.-D. Chern, K.-J. Chang, C.-W. Cheng, S.-M. Hsu, and C.-Y. Shen Breast Cancer Risk Associated with Genotype Polymorphism of the Estrogen-metabolizing Genes CYP17, CYP1A1, and COMT: A Multigenic Study on Cancer Susceptibility Cancer Res., October 1, 1999; 59(19): 4870 - 4875. [Abstract] [Full Text] [PDF]